Nearly nine in ten Ontarians agree that Government should make it a priority to help strengthen the domestic generic pharmaceutical industry to ensure the supply of prescription medicines (87%, 83% in 2021).
Just under half of Ontarians (49%) agree that Governments in Canada should not cut the prices of generic prescription medicines if it could lead to less domestic production and drug shortages. Older Canadians (55 plus) were more likely to agree with this (mean of 6.7 out of 10) than younger Ontarians (18-34, mean of 6.0 out of 10).
Nanos conducted an RDD dual frame (land- and cell-lines) hybrid telephone and online random survey of 500 Ontarians, 18 years of age or older, between November 27th and December 1st, 2022. The margin of error for a random survey of 500 Ontarians is ±4.4 percentage points, 19 times out of 20.
The research was commissioned by the Canadian Generic Pharmaceutical Association and was conducted by Nanos Research.
To read the full report, click here.